Iwasaki T, Nozima T
J Immunol. 1977 Jan;118(1):256-63.
To investigate the defensive roles and production of interferon and antibodies, C3H/He mice were subjected to various immunosuppressive treatments and infected with influenza virus. In infected normal control mice the pattern of pulmonary viral growth can be divided into three phases. The first phase is characterized by an exponential increase of virus titer, the second by a rapid decrease, and the third by a moderate decrease. At the time of transition from the first phase to the second in pulmonary virus growth, interferon could be detected in the tracheobronchial washings of infected mice, but neutralizing antibodies could not. In infected B cell-deprived mice and infected anti-mu-treated mice, the transition from the first phase to the second occurred without any detectable antibody production, and interferon could be induced in the early stage of infection. However, the pulmonary virus in these mice increased again exponentially until the death of the mice. In infected T cell-deprived mice which could not induce interferon, but produced IgM-neutralizing antibodies, the second phase was not observed after the first phase, but a transient plateau phase could be demonstrated, and then the pulmonary virus increased again exponentially until the death of the mice. In anti-gamma-treated infected mice, pulmonary virus growth and production of interferon and neutralizing antibody were almost similar to those of infected normal control mice except for the absence of IgG neutralizing antibody production. Although anti-alpha-treated infected mice produced interferon and no IgA antibody, the transition from the first exponential increase of pulmonary virus to the second rapid decrease was seen, but then the virus increased exponentially again until the death of the mice. These results suggest that interferon plays an important role in the transition from the first phase to the second, and that T cells are required for interferon induction in mice infected with influenza virus. These data also suggest that IgA antibodies play an important role in the inhibition of virus propagation in the lungs after the disappearance of interferon. Moreover, infected T cell-deprived mice could produce only IgM neutralizing antibodies, but not IgG and IgA antibodies. Therefore, T cells are required for the production of IgG and IgA antibodies and even
为了研究干扰素和抗体的防御作用及产生情况,对C3H/He小鼠进行了各种免疫抑制处理,并使其感染流感病毒。在感染的正常对照小鼠中,肺部病毒生长模式可分为三个阶段。第一阶段的特征是病毒滴度呈指数增长,第二阶段是快速下降,第三阶段是适度下降。在肺部病毒生长从第一阶段过渡到第二阶段时,可在感染小鼠的气管支气管灌洗液中检测到干扰素,但检测不到中和抗体。在感染的B细胞缺失小鼠和感染的抗μ处理小鼠中,从第一阶段到第二阶段的过渡在没有任何可检测到的抗体产生的情况下发生,并且在感染早期可诱导产生干扰素。然而,这些小鼠肺部的病毒再次呈指数增长,直至小鼠死亡。在不能诱导干扰素但能产生IgM中和抗体的感染T细胞缺失小鼠中,第一阶段后未观察到第二阶段,但可显示出一个短暂的平台期,然后肺部病毒再次呈指数增长,直至小鼠死亡。在抗γ处理的感染小鼠中,除了不产生IgG中和抗体外,肺部病毒生长以及干扰素和中和抗体的产生与感染的正常对照小鼠几乎相似。尽管抗α处理的感染小鼠产生了干扰素且没有IgA抗体,但可观察到肺部病毒从第一次指数增长向第二次快速下降的转变,但随后病毒再次呈指数增长,直至小鼠死亡。这些结果表明,干扰素在从第一阶段到第二阶段的转变中起重要作用,并且在感染流感病毒的小鼠中,T细胞是诱导干扰素所必需的。这些数据还表明,在干扰素消失后,IgA抗体在抑制肺部病毒传播中起重要作用。此外,感染的T细胞缺失小鼠只能产生IgM中和抗体,而不能产生IgG和IgA抗体。因此,T细胞是产生IgG和IgA抗体所必需的,甚至